View Author
patient tumor liver cancer survival resection study metastase melanoma treatment surgery oncol group disease lymph result month hepatic rectal cancer sentinel colorectal carcinoma factor rectal hepatocellular carcinoma tumour chemotherapy recurrence signi table perfusion analysis colorectal liver metastases hepatocellular liver metastases prognostic response sarcoma limb perfusion therapy number outcome range tissue melphalan procedure trial radiotherapy follow-up complication stage neoadjuvant chemotherapy sn tumor burden metastatic liver resection center dissection neoadjuvant control burden value signi ficantly biopsy rotterdam margin necrosis sentinel node lymph node dissection netherland preoperative sentinel node biopsy ficant prognostic factors verhoef colorectal cancer thickness hepatic resection toxicity lymph nodes ablation
10 Most Recent Publications
|
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
(Article)
Mostert, B. Jiang, Y. Spoel, P. van der Ramírez-Moreno, R. Verhoef, C. IJzermans, J.N.M. Gratama, J-W. Foekens, J.A. Sleijfer, S. Martens, J.W.M. Sieuwerts, A.M. Wang, H. Bolt-de Vries, J. Biermann, K. Kraan, J. Lalmahomed, Z.S. Galen, A. van Weerd, V. de |
2013-07-01
|
|
Increased alpha-fetoprotein serum level is predictive for survival and recurrence of hepatocellular carcinoma in non-cirrhotic livers
(Article)
Witjes, C.D.M. Polak, W.G. Verhoef, C. Eskens, F.A.L.M. Dwarkasing, R.S. Verheij, J. Man, R.A. de IJzermans, J.N.M. |
2013-04-01
|
|
Recently introduced biomarkers for screening of hepatocellular carcinoma: A systematic review and meta-analysis
(Article)
Witjes, C.D.M. Aalten, S.M. van Steyerberg, E.W. Borsboom, G.J.J.M. Man, R.A. de Verhoef, C. IJzermans, J.N.M. |
2013-01-01
|
|
Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: A plea against
(Article)
Witjes, C.D.M. Kate, F.J.W. ten Aalten, S.M. van Dwarkasing, R.S. Willemssen, F.E.J.A. Verhoef, C. Man, R.A. de IJzermans, J.N.M. |
2012-11-01
|
|
Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection
(Article)
Ploeg, A.P.T. van der Akkooi, A.C.J. van Rutkowski, P. Cook, M. Nieweg, O.E. Rossi, C.R. Testori, A. Suciu, S. Verhoef, C. Eggermont, A.M.M. |
2012-10-01
|
|
Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: A population-based series
(Article)
Pool, A.E.M. van der Damhuis, R.A. IJzermans, J.N.M. Wilt, J.H.W. de Eggermont, A.M.M. Kranse, R. Verhoef, C. |
2012-01-01
|
|
Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases
(Article)
Deroose, J.P. Grünhagen, D.J. Geel, A.N. van Wilt, J.H.W. de Eggermont, A.M.M. Verhoef, C. |
2011-11-01
|
|
Long-term results of tumor necrosis factor α- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas
(Article)
Deroose, J.P. Eggermont, A.M.M. Geel, A.N. van Burger, J.W.A. Bakker, M.A. den Wilt, J.H.W. de Verhoef, C. |
2011-10-20
|
|
Outcome of Microscopic Incomplete Resection (R1) of Colorectal Liver Metastases in the Era of Neoadjuvant Chemotherapy
(Article)
Ayez, N. Lalmahomed, Z.S. Eggermont, A.M.M. IJzermans, J.N.M. Jonge, J. de Montfort, C.A.G.M. van Verhoef, C. |
2011-10-17
|
|
Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?
(Article)
Ayez, N. Lalmahomed, Z.S. Pool, A.E.M. van der Vergouwe, Y. Montfort, C.A.G.M. van Jonge, J. de Eggermont, A.M.M. IJzermans, J.N.M. Verhoef, C. |
2011-10-01
|
